Process control procedures to augment quality control of leukocyte-reduced red cell blood products

被引:0
|
作者
Finch, SJ [1 ]
Chen, JB
Chen, CH
Hall, MM
Matkovich, V
Wenz, B
Brandwein, H
Whitbread, J
机构
[1] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA
[2] Pall Corp, Dept Sci, Port Washington, NY 11050 USA
[3] Pall Corp, Lab Serv, Port Washington, NY 11050 USA
关键词
D O I
10.1002/(SICI)1097-0258(19990530)18:10<1279::AID-SIM112>3.0.CO;2-6
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quality control of leukocyte-reduced packed red cell units (LRprc) produced in blood facilities must conform to regulatory criteria, which state that units may not contain more than 1 X 10(6) to 5 X 10(6) white blood cells (WBC) per unit. The post-filtration WBC content of a total of n = 386 LRprc units was counted with a Nageotte chamber to model the probability that a unit would not meet the regulatory criteria. The distribution of the residual leukocyte counts is close to a negative binomial distribution (NBD) and is independent of the packed red cell volume filtered. The observed probability that a unit of blood has a residual WBC greater than 5 X 10(6) is 2.6 +/- 2.6 X 10(-3). A power analysis of the two-sample Kolmogorov-Smirnov (KS) test in this application shows that a sample size of 20 is sufficient for determining that the process is in control when an out of control process has a k NBD parameter greater than or equal to that of the in control process. The three out of control processes observed to date appear to have this property. A sample of size 80 may be necessary for confirming that process validation data sets conform to the larger 'reference' database (n = 386) for processes that are out of control in such a way that their k NBD parameter is less than the k parameter of the in control process. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:1279 / 1289
页数:11
相关论文
共 50 条
  • [21] Quality control of blood cell products -: Collecting samples?
    Bégué, S
    Vidal-Obert, M
    Girard, A
    Perrault, MP
    Leroy, MC
    Masse, M
    Royer, D
    Peyrard, T
    Assens, C
    David, C
    Day, B
    Arzur, C
    Boudib, C
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1999, 6 (06) : 403 - 408
  • [22] Allogeneic Leukocyte-Reduced Red Blood Cell Transfusion Is Associated with Postoperative Infectious Complications and Cancer Recurrence after Colon Cancer Resection
    Deeb, Andrew-Paul
    Aquina, Christopher T.
    Monson, John R. T.
    Blumberg, Neil
    Becerra, Adan Z.
    Fleming, Fergal J.
    DIGESTIVE SURGERY, 2020, 37 (02) : 163 - 170
  • [24] Prevention of transfusion-transmitted CMV viremia using leukocyte-reduced blood products in seronegative UCBT patients
    Shigemura, Tomonari
    Kurata, Takashi
    Komori, Kazutoshi
    Morita, Daisuke
    Tanaka, Miyuki
    Sakashita, Kazuo
    Nakazawa, Yozo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 514 - 514
  • [25] Is poor, glycemic control associated with reduced red blood cell lifespan?
    Cohen, RM
    Franco, R
    Joiner, CH
    DIABETES CARE, 2004, 27 (04) : 1013 - 1014
  • [26] Evaluation of Methodologies for Quality Control of Red Blood Cell Components
    Kline, L.
    George, G. M.
    Keegan, T. E.
    Kugele, F.
    Hill, C. L.
    TRANSFUSION, 2010, 50 : 73A - 73A
  • [27] Febrile non-hemolytic transfusion reactions reported in patients receiving prestorage leukocyte-reduced or non-leukocyte-reduced red blood cells or apheresis platelets
    Becker, JL
    Boyd, JC
    Mintz, PD
    TRANSFUSION, 2001, 41 (09) : 112S - 113S
  • [28] Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial
    Collier, AC
    Kalish, LA
    Busch, MP
    Gernsheimer, T
    Assmann, SF
    Lane, TA
    Asmuth, DM
    Lederman, MM
    Murphy, EL
    Kumar, P
    Kelley, M
    Flanigan, TP
    McMahon, DK
    Sacks, HS
    Kennedy, MS
    Holland, PV
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (12): : 1592 - 1601
  • [29] Evaluation of using cyto-chek® to preserve specimens for counting residual leukocytes in leukocyte-reduced red cell (RBC) and platelet (PLT) products.
    Yorek, HJ
    Alvey, SA
    Zabel, TL
    TRANSFUSION, 1998, 38 (10) : 6S - 6S
  • [30] Comparing alloimmunization in preterm infants after transfusion of fresh unmodified versus stored leukocyte-reduced red blood cells
    Strauss, RG
    Cordle, DG
    Quijana, J
    Goeken, NE
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (03) : 224 - 230